Tuesday, 18 January 2022

 

 

LATEST NEWS Mission Youth initiative enables many Kishtwar youth to earn livelihood with dignity DC Rajouri flags off 4 Advance Life Saving Ambulances DC Kupwara for implementation of Covid norms DC Ganderbal visits Sonamarg, takes stock of availability of essential services and other facilities “Awaam Ki Awaaz” : Lt Governor enlists breakthrough steps and initiatives for economic growth and equitable development of J&K ECI Reschedules Punjab Assembly Polls To February 20, 2022, Informs CEO Punjab Bandaru Dattatraya flagged off two trucks containing 4000 hygiene kits prepared by the Indian Red Cross Society Two time MLA Luv Kumar Goldy joins Punjab Lok Congress State Government proposes outlay of Rs. 12638 crore for budget 2022-23 Governor asks experts to provide holistic solution to make Himachal a role model for landslide risk resilient state If given an opportunity, it will be an honour: Jasprit Bumrah on captaincy Sushil Pandey talks about his working experience in 'Human' Rahul Bansal goes bad, turns villain in cop drama 'Bhaukaal 2' Nearly 3 cr Covid vaccines administered in Delhi: Satyendar Jain How Akshita Mudgal wore a 28-kg lehenga for wedding sequence in 'Iss Mod Se Jaate Hain' I'd always love to be part of Marathi showbiz : Aditya Deshmukh Virat Kohli told us after Cape Town Test that he will be stepping down from captaincy: Jasprit Bumrah Equities continue gains, settle marginally up CHJU Submitted memorandum to Power Minister Ranjit Singh & Transport Minister Mool Chand Sharma regarding demands of the journalists No. 1 Ashleigh Barty begins quest for first Australian Open title with easy win Delhi govt aims to bring 2,000 electric buses in coming years: Arvind Kejriwal

 

Covid-19 vaccine: Zydus Cadila to begin phase-2 clinical trials

Web Admin

Web Admin

5 Dariya News

New Delhi , 05 Aug 2020

Drug firm Zydus Cadila on Wednesday announced that its plasmid DNA vaccine to prevent COVID-19 -- ZyCoV-D -- was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from August 6.The company stated that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, were well tolerated."We now begin the phase II clinical trials and look forward to evaluating the safety and immunogenicity of the vaccine in a larger population," said Pankaj R. Patel, Chairman of Zydus Cadila.He also said that all the subjects in the phase I clinical trial were closely monitored in a clinical pharmacological unit for 24 hours post dosing for safety and for seven days thereafter and the vaccine was found to be very safe.The statement came a day after Director General of Indian Council of Medical Research Balram Bhargava said that the DNA vaccine by Zydus Cadila has completed phase I trials and embarked on phase II at 11 sites.Previously, the vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies. The vaccine was able to elicit a high level of neutralisation of antibodies in animal studies.The phase II trial will be evaluating the humoral and cellular immune response for the vaccine candidate in line with the current global clinical trial protocols in general.With ZyCoV-D, the company has successfully established the DNA vaccine platform in the country using non-replicating and non-integrating plasmid carrying the gene of interest making it very safe.The plasmid DNA when introduced into the host cells would be translated into the viral protein and will elicit a strong immune response mediated by the cellular and humoral arms of the human immune system, which play a vital role in protection from disease as well as viral clearance.Besides this, ICMR chief Balram Bhargava had also said that the inactivated virus vaccine by Bharat Biotech has completed its phase I study at 11 sites and has started its phase II study."There is no specific drug or vaccine available yet. The need for the vaccine is great and urgent but there is a dilemma - the pandemic is progressing rapidly and developing the vaccine may take time," he had said.According to the ICMR, there are 141 vaccine candidates which are being studied the world over, o

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Pandemic , Novavax Covid-19 , Zydus Cadila , DNA vaccine , Covid-19 Vaccine

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD